Cargando…
Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk
Prostate cancer is the most frequent and second most lethal cancer in men in the United States. Innate immunity and inflammation may increase the risk of prostate cancer. To determine the role of innate immunity and inflammation in advanced prostate cancer, we investigated the association of 320 sin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522730/ https://www.ncbi.nlm.nih.gov/pubmed/23272139 http://dx.doi.org/10.1371/journal.pone.0051680 |
_version_ | 1782253124658921472 |
---|---|
author | Kazma, Rémi Mefford, Joel A. Cheng, Iona Plummer, Sarah J. Levin, Albert M. Rybicki, Benjamin A. Casey, Graham Witte, John S. |
author_facet | Kazma, Rémi Mefford, Joel A. Cheng, Iona Plummer, Sarah J. Levin, Albert M. Rybicki, Benjamin A. Casey, Graham Witte, John S. |
author_sort | Kazma, Rémi |
collection | PubMed |
description | Prostate cancer is the most frequent and second most lethal cancer in men in the United States. Innate immunity and inflammation may increase the risk of prostate cancer. To determine the role of innate immunity and inflammation in advanced prostate cancer, we investigated the association of 320 single nucleotide polymorphisms, located in 46 genes involved in this pathway, with disease risk using 494 cases with advanced disease and 536 controls from Cleveland, Ohio. Taken together, the whole pathway was associated with advanced prostate cancer risk (P = 0.02). Two sub-pathways (intracellular antiviral molecules and extracellular pattern recognition) and four genes in these sub-pathways (TLR1, TLR6, OAS1, and OAS2) were nominally associated with advanced prostate cancer risk and harbor several SNPs nominally associated with advanced prostate cancer risk. Our results suggest that the innate immunity and inflammation pathway may play a modest role in the etiology of advanced prostate cancer through multiple small effects. |
format | Online Article Text |
id | pubmed-3522730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35227302012-12-27 Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk Kazma, Rémi Mefford, Joel A. Cheng, Iona Plummer, Sarah J. Levin, Albert M. Rybicki, Benjamin A. Casey, Graham Witte, John S. PLoS One Research Article Prostate cancer is the most frequent and second most lethal cancer in men in the United States. Innate immunity and inflammation may increase the risk of prostate cancer. To determine the role of innate immunity and inflammation in advanced prostate cancer, we investigated the association of 320 single nucleotide polymorphisms, located in 46 genes involved in this pathway, with disease risk using 494 cases with advanced disease and 536 controls from Cleveland, Ohio. Taken together, the whole pathway was associated with advanced prostate cancer risk (P = 0.02). Two sub-pathways (intracellular antiviral molecules and extracellular pattern recognition) and four genes in these sub-pathways (TLR1, TLR6, OAS1, and OAS2) were nominally associated with advanced prostate cancer risk and harbor several SNPs nominally associated with advanced prostate cancer risk. Our results suggest that the innate immunity and inflammation pathway may play a modest role in the etiology of advanced prostate cancer through multiple small effects. Public Library of Science 2012-12-14 /pmc/articles/PMC3522730/ /pubmed/23272139 http://dx.doi.org/10.1371/journal.pone.0051680 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Kazma, Rémi Mefford, Joel A. Cheng, Iona Plummer, Sarah J. Levin, Albert M. Rybicki, Benjamin A. Casey, Graham Witte, John S. Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk |
title | Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk |
title_full | Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk |
title_fullStr | Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk |
title_full_unstemmed | Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk |
title_short | Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk |
title_sort | association of the innate immunity and inflammation pathway with advanced prostate cancer risk |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522730/ https://www.ncbi.nlm.nih.gov/pubmed/23272139 http://dx.doi.org/10.1371/journal.pone.0051680 |
work_keys_str_mv | AT kazmaremi associationoftheinnateimmunityandinflammationpathwaywithadvancedprostatecancerrisk AT meffordjoela associationoftheinnateimmunityandinflammationpathwaywithadvancedprostatecancerrisk AT chengiona associationoftheinnateimmunityandinflammationpathwaywithadvancedprostatecancerrisk AT plummersarahj associationoftheinnateimmunityandinflammationpathwaywithadvancedprostatecancerrisk AT levinalbertm associationoftheinnateimmunityandinflammationpathwaywithadvancedprostatecancerrisk AT rybickibenjamina associationoftheinnateimmunityandinflammationpathwaywithadvancedprostatecancerrisk AT caseygraham associationoftheinnateimmunityandinflammationpathwaywithadvancedprostatecancerrisk AT wittejohns associationoftheinnateimmunityandinflammationpathwaywithadvancedprostatecancerrisk |